Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
Journal of Virology|June 22, 2012
Characterization in vitro and in vivo of pandemic (H1N1) 2009 influenza viruses isolated from patientsTokiko Watanabe, Masaki Imai, Shinji Watanabe, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025Caroline Kikawa, John Huddleston, Andrea N Loes, et al.
Virus Evolution|November 25, 2025
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025Caroline Kikawa, John Huddleston, Andrea N Loes, et al.
Cancer Science|March 20, 2026
Expression of Glycoprotein B (gB) Correlates With Poor Prognosis in Nasopharyngeal CarcinomaShigetaka Komura, Satoru Kondo, Hideya Kawasaki, et al.
Nature|November 2, 2022
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodentsRyuta Uraki, Peter J Halfmann, Shun Iida, et al.
Frontiers in Plant Science|November 3, 2025
<i>Bacillus siamensis</i> CCT8089: a novel phosphate-solubilizing bacterium enhancing maize and soybean growthMirela Mosela, Galdino Andrade, Alison Fernando Nogueira, et al.
Plos One|March 5, 2020
Epidemic of influenza A(H1N1)pdm09 analyzed by full genome sequences and the first case of oseltamivir-resistant strain in Myanmar 2017Su Mon Kyaw Win, Reiko Saito, Nay Chi Win, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United StatesAmanda C Perofsky, John Huddleston, Chelsea Hansen, et al.
Frontiers in Plant Science|March 2, 2026
<i>Bacillus velezensis</i> Ag129 and Ag132: two novel probiotics enhancing drought tolerance and agronomic performance in maize and soybeanAntoni Wallace Marcos, Juarez Pires Tomaz, Alison Fernando Nogueira, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selectionCaroline Kikawa, John Huddleston, Sam A Turner, et al.
Pageof 21